Skip to content
Logo Centauri Therapeutics
  • About Us
    • About Us
    • Our Team
  • Pipeline
    • Pipeline
    • Anti-infectives
    • Oncology
  • Science
    • Science
    • The Alphamer Platform
    • Innate Immune System
  • News & Events
    • Press Releases
    • Events
    • Resources
  • Investors
  • Contact

Resources

Find our latest research and published materials

Logo Centauri Therapeutics
  1. Home
  2. Resources
Resource TitleLink to Resource
Journal publicationHarnessing endogenous anti-glycan antibodies using a novel, bifunctional immunotherapy to treat gram-negative bacterial infections
Drug Discovery OnlineDiscovery Dialogues Helen Bright PhD CSO of Centauri Tx
Drug Discovery WorldImmune therapy – harnessing the host response
The Medicine MakerBiotech Versus the Superbugs
Drug Development and DeliveryDeveloping Innovative Solutions to One of the Top Public Health Threats: Antibacterial Resistance
Technology NetworksHarnessing the Immune System To Combat Antimicrobial Resistance
Drug Target ReviewWhy antibiotics alone are no longer enough in fighting infection | Drug Target Review
logo-centauri-full-light

+44 (0)1625 238620

info@centauritherapeutics.com

Address

Centauri Therapeutics Ltd
Alderley Park
Nether Alderley
Cheshire
SK10 4TG

logo-investors-in-people
logo-linkedin
  • About Us
  • Pipeline
  • Science
  • News & Events
  • Investors
  • Contact
  • Privacy Policy
  • Cookies

© Copyright 2026 Centauri Therapeutics Limited | Company number: 08879741

Website by Indigo Tree (opens a new window)